A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders. A person-centered, nonjudgmental approach should be adopted.

Alcohol abstinence alters brain activity in ways that may drive someone with alcohol use disorder to relapse, new research in ...

Once weekly semaglutide injections reduced alcohol consumption in patients with alcohol use disorder (AUD) and comorbid obesity. Results of the randomized controlled trial (RCT), the first, to the ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...

What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...

A 26-week, randomized, double-blind trial in Copenhagen enrolled adults 18–70 years with AUD, BMI ≥30 kg/m², ≥6 heavy-drinking days, and AUDIT >15, assigning semaglutide vs placebo 1:1. Compared with ...